While most of America is still struggling to legalize marijuana for medicinal purposes, a handful of large pharmaceutical companies are already generating a substantial amount of revenue from prescription drugs based on cannabis medicine.
While most of America is still struggling to legalize marijuana for medicinal purposes, a handful of large pharmaceutical companies are already generating a substantial amount of revenue from prescription drugs based on cannabis medicine.